GenAI’s large language models will transform safety & regulatory processes
Up to now, AI technology has had to be painstakingly ‘trained’ in what to look for.
Up to now, AI technology has had to be painstakingly ‘trained’ in what to look for.
When saddled with legacy medical information systems, Medical Affairs teams ...
At this year’s DIA Global Annual Conference, ArisGlobal presented an Innovation Theater session, “Getting More Value from Your Data Through a Unified, Cross-Department Platform.” Wim Cypers, Senior Vice President of Regulatory, highlighted use cases where automation can be used to improve business processes to enhance data quality and improved business process efficiencies.
As the pharmaceutical industry adapts to a new world with ...
Individual Case Safety Reports, or ICSRs, are a large part ...
There has been significant changes in the way the EMA expects MAHs to handle ICSRs from the new EudraVigilance system, creating additional work for already busy pharmacovigilance departments
In the ever-evolving world of pharmaceuticals, a leading company has embarked on a transformative journey by moving its regulatory operations to the cloud.
Safety is evolving rapidly. There is a major, emerging opportunity ...
EMA SPOR Working group release the details to the SPOR ...
Safety departments at Marketing Authorization Holders & Regulatory Authorities are ...
ArisGlobal is a pivotal partner in the life sciences industry, specializing in solutions that drive drug development, safety monitoring, and regulatory compliance. We collaborate with more than 220 global life sciences companies, CROs, and government health authorities, including leading biopharmaceutical firms and regulatory bodies such as FDA, Health Canada, and NMPA.
Headquartered in the United States, ArisGlobal has regional offices in Europe, India, Japan and China.
Quick Links
© 2024 ArisGlobal – All Rights Reserved